Page 159 - Read Online

Ghunaim et al. Vessel Plus 2023;7:29 https://dx.doi.org/10.20517/2574-1209.2023.112 Page 13 of 17

26. Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the management of patients with
chronic coronary disease: a report of the american heart association/American college of cardiology joint committee on clinical
practice guidelines. J Am Coll Cardiol 2023;82:833-955. DOI
27. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the
american college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol
2022;79:e263-421. DOI
28. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive
summary: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines.
Circulation 2022;145:e4-17. DOI
29. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure:
developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology
(ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2021;42:3599-726. DOI
30. McDonald M, Virani S, Chan M, et al. CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for
heart failure with reduced ejection fraction. Can J Cardiol 2021;37:531-46. DOI
31. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention
2019;14:1435-534. DOI
32. Ezekowitz JA, O'Meara E, McDonald MA, et al. 2017 comprehensive update of the canadian cardiovascular society guidelines for the
management of heart failure. Can J Cardiol 2017;33:1342-433. DOI
33. Vervoort D, Jolicoeur ME, Marquis-Gravel G, Fremes SE. Is the world ready for the STICH 3.0 trial? Curr Opin Cardiol
2022;37:474-80. DOI PubMed
34. Parikh PB, Bhatt DL, Bhasin V, et al. Impact of percutaneous coronary intervention on outcomes in patients with heart failure: JACC
state-of-the-art review. J Am Coll Cardiol 2021;77:2432-47. DOI
35. Fearon WF, Zimmermann FM, De Bruyne B, et al. Fractional flow reserve-guided PCI as compared with coronary bypass surgery. N
Engl J Med 2022;386:128-37. DOI
36. Fremes SE, Marquis-Gravel G, Gaudino MFL, et al. STICH3C: rationale and study protocol. Circ Cardiovasc Interv
2023;16:e012527. DOI
37. Patient-Centered outcomes research institute award will fund RECHARGE trials of PCI versus CABG in women and minority
groups. 2023. Available from: https://citoday.com/news/patient-centered-outcomes-research-institute-award-will-fund-recharge-
trials-of-pci-versus-cabg-in-women-and-minority-groups [Last accessed on 24 Nov 2023].
38. He J, Morales DR, Guthrie B. Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic
review. Trials 2020;21:228. DOI PubMed PMC
39. Tan YY, Papez V, Chang WH, Mueller SH, Denaxas S, Lai AG. Comparing clinical trial population representativeness to real-world
populations: an external validity analysis encompassing 43895 trials and 5685738 individuals across 989 unique drugs and 286
conditions in England. Lancet Healthy Longev 2022;3:e674-89. DOI
40. Veronese ET, Pomerantzeff PMA, Jatene FB. Improving the heart team: an interdisciplinary team and integrated practice unit. World
J Cardiol 2021;13:650-3. DOI PubMed PMC
41. Ryan M, Morgan H, Chiribiri A, Nagel E, Cleland J, Perera D. Myocardial viability testing: all STICHed up, or about to be
REVIVED? Eur Heart J 2022;43:118-26. DOI
42. Garcia MJ, Kwong RY, Scherrer-Crosbie M, et al. State of the art: imaging for myocardial viability: a scientific statement from the
american heart association. Circ Cardiovasc Imaging 2020;13:e000053. DOI
43. Hwang HY, Yeom SY, Park EA, Lee W, Jang MJ, Kim KB. Serial cardiac magnetic resonance imaging after surgical coronary
revascularization for left ventricular dysfunction. J Thorac Cardiovasc Surg 2020;159:1798-805. DOI PubMed
44. Panza JA, Ellis AM, Al-Khalidi HR, et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N Engl J Med
2019;381:739-48. DOI
45. Dastidar AG, Baritussio A, De Garate E, et al. Prognostic role of CMR and conventional risk factors in myocardial infarction with
nonobstructed coronary arteries. JACC Cardiovasc Imaging 2019;12:1973-82. DOI
46. Mieres JH, Gulati M, Bairey Merz N, et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic
heart disease: a consensus statement from the American Heart Association. Circulation 2014;130:350-79. DOI
47. He GW, Taggart DP. Spasm in arterial grafts in coronary artery bypass grafting surgery. Ann Thorac Surg 2016;101:1222-9. DOI
48. Silva M, Rong LQ, Naik A, et al. Intraoperative graft flow profiles in coronary artery bypass surgery: a meta-analysis. J Card Surg
2020;35:279-85. DOI
49. Chikwe J, Sun E, Hannan EL, et al. Outcomes of second arterial conduits in patients undergoing multivessel coronary artery bypass
graft surgery. J Am Coll Cardiol 2019;74:2238-48. DOI
50. Mohammadi S, Kalavrouziotis D, Cresce G, et al. Bilateral internal thoracic artery use in patients with low ejection fraction: is there
any additional long-term benefit? Eur J Cardiothorac Surg 2014;46:425-31. DOI
51. Jawitz OK, Lawton JS, Thibault D, et al. Sex differences in coronary artery bypass grafting techniques: a society of thoracic surgeons
database analysis. Ann Thorac Surg 2022;113:1979-88. DOI
52. Jabagi H, Tran DT, Hessian R, Glineur D, Rubens FD. Impact of gender on arterial revascularization strategies for coronary artery
bypass grafting. Ann Thorac Surg 2018;105:62-8. DOI PubMed